ReviewCerebellum (London, England)2025
Neurodevelopmental Outcome in Isolated Vermian Hypoplasia: A Single-Center Retrospective Cohort Study and Literature Review.
Review in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vermian hypoplasia (VH) is characterized by reduced cerebellar vermis volume without significant hemispheric involvement. To date, data on long-term neurodevelopmental outcomes in isolated VH cases are limited, complicating prenatal counselling. This is single-center retrospective cohort study analyzing fetuses with posterior fossa abnormalities (PFA) diagnosed between 2010 and 2021. VH cases were confirmed through ultrasonography and fetal MRI, excluding non-isolated anomalies or ischemic/hemorrhagic etiologies. We collected data on Neurodevelopmental outcomes through chart review and structured interviews with the caregiver. We also provided a literature review summarizing prior research on VH outcomes. Out of 45 cases with (PFA), isolated VH was found in 15 children and was confirmed in 7 cases through fetal MRI. Among these patients, median gestational age at diagnosis was 22.5 weeks, with follow-ups extending to a median age of 6 years. Age-appropriate neurodevelopmental outcomes were normal or showed minimal deficits in 6/7 (70%). Literature review highlighted a wide outcome variability, partly due to varying diagnostic criteria and follow-up protocols. Long-term prognosis is influenced by various factors, including genetic testing and environmental support. In isolated VH, outcomes are generally favorable, though mild learning or motor coordination deficits may emerge. Broader normative biometrics and consistent neurodevelopmental evaluations are critical for improved prognostic precision. VH presents diagnostic and prognostic challenges due to variability in outcomes and limited longitudinal data. A multidisciplinary approach, including prenatal imaging, genetic testing, and structured follow-up, is essential for effective family counseling and developmental support. Prospective studies with larger cohorts are warranted to establish clearer guidelines.
Indexed as
Identifiers
40100516What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.